Bio Pharma/Defense Play

McAndrews & Forbes, the investment vehicle for billionaire Ronald Perelman, increased its holdings to 14,659,344 shares (33.2%), after purchasing 3,851,969 shares on Sept. 30 at $6.24 per share. The holding company bought the stock from TransTech Pharma, a company in which it holds a majority stake. McAndrews & Forbes paid $6 million cash and issued a promissory note for approximately $18 million. The shares McAndrews purchased include 1,379,747 shares which TransTech Pharma had acquired at $1.90 per share via a warrant exercise on Sept. 30.

medical play

Best Biotech with lots of contracts for thier Smallpox Cure from Governments

block buster life saving drugs where no else exists.

Speculative. Once the small pox vaccine is approved by FDA, it will go high

Vaccine up for approval

smallpox vaccine

http://SIGA.group.stockfriend.com

Speculation

Speculative BioPharma, Defense, Management

Look at the 5 year history -- from 3 down to 1 and back up to 4. EPS is still negative.